Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Gongwin Biopharm Holdings Co., Ltd. (6617) Income Statement

Gongwin Biopharm Holdings Co., Ltd. Income Statement

Last quarter (Q2 2026), Gongwin Biopharm Holdings Co., Ltd.'s total revenue was NT$12.69M, an increase of 45.05% from the same quarter last year. In Q2, Gongwin Biopharm Holdings Co., Ltd.'s net income was NT$-42.35M. See Gongwin Biopharm Holdings Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Mar 24Mar 23Dec 21
NT$ 36.45MNT$ 32.04MNT$ 18.91MNT$ 1.14MNT$ 1.14M
NT$ 14.99MNT$ 8.68MNT$ 11.20MNT$ 1.07MNT$ 1.08M
NT$ 222.28MNT$ 170.74MNT$ 144.53MNT$ 261.75MNT$ 121.90M
Depreciation and AmortizationNT$ 11.10MNT$ 11.59MNT$ 13.33MNT$ 13.39MNT$ 12.96M
NT$ -196.19MNT$ -75.97MNT$ -81.05MNT$ -275.56MNT$ -100.58M
NT$ -207.29MNT$ -162.06MNT$ -133.33MNT$ -288.95MNT$ -113.54M
NT$ 86.42MNT$ 70.20MNT$ 32.15MNT$ -31.45MNT$ 6.11M
NT$ -120.87MNT$ -91.86MNT$ -101.17MNT$ -292.13MNT$ -114.72M
NT$ -114.13MNT$ -82.55MNT$ -92.04MNT$ -254.19MNT$ -121.58M
Per Share Metrics
Basic EPSNT$ -0.92NT$ -0.68NT$ -0.81NT$ -2.29NT$ -1.10
Diluted EPSNT$ -0.92NT$ -0.68NT$ -0.81NT$ -2.29NT$ -1.10
Weighted Average Shares Outstanding123.43M120.79M113.27M111.13M110.86M
Weighted Average Shares Outstanding (Diluted)123.43M120.79M113.27M111.13M110.86M

Currency in TWD

Gongwin Biopharm Holdings Co., Ltd. Earnings and Revenue History

-300M-150M0150M-60000 %-40000 %-20000 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin